Financials
- Market Capitalization 170.46 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.38
Relación precio/flujo de caja
18.82
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3724 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.69 USD | -3.40% | -5.14% | +1.93% | +92.19% | 174.85 M USD | ||
| 3731 | TLSA Tiziana Life Sciences Ltd - Common Shares | 1.43 USD | +7.52% | +15.32% | +23.28% | -2.05% | 172.33 M USD | ||
| 3736 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.73 USD | +3.96% | +7.74% | -0.21% | +337.96% | 170.36 M USD | ||
| 3744 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.80 USD | +0.56% | -4.76% | -0.55% | +5.26% | 168.69 M USD |